Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17364219rdf:typepubmed:Citationlld:pubmed
pubmed-article:17364219lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:17364219lifeskim:mentionsumls-concept:C0007226lld:lifeskim
pubmed-article:17364219lifeskim:mentionsumls-concept:C1956346lld:lifeskim
pubmed-article:17364219lifeskim:mentionsumls-concept:C1522564lld:lifeskim
pubmed-article:17364219lifeskim:mentionsumls-concept:C0046056lld:lifeskim
pubmed-article:17364219lifeskim:mentionsumls-concept:C0733755lld:lifeskim
pubmed-article:17364219lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:17364219lifeskim:mentionsumls-concept:C0917874lld:lifeskim
pubmed-article:17364219lifeskim:mentionsumls-concept:C0040395lld:lifeskim
pubmed-article:17364219lifeskim:mentionsumls-concept:C0233929lld:lifeskim
pubmed-article:17364219pubmed:issue6lld:pubmed
pubmed-article:17364219pubmed:dateCreated2007-11-2lld:pubmed
pubmed-article:17364219pubmed:abstractTextThe aim of this study was to assess the value of contrast-enhanced cardiovascular magnetic resonance (CMR) in viability for patients with coronary artery disease and left ventricular (LV) dysfunction (ejection fraction [EF] </=50%), comparing to gated thallium-201 ((201)Tl) single photon emission computed tomography (SPECT) and (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET).lld:pubmed
pubmed-article:17364219pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17364219pubmed:languageenglld:pubmed
pubmed-article:17364219pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17364219pubmed:citationSubsetIMlld:pubmed
pubmed-article:17364219pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17364219pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17364219pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17364219pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17364219pubmed:statusMEDLINElld:pubmed
pubmed-article:17364219pubmed:monthDeclld:pubmed
pubmed-article:17364219pubmed:issn1569-5794lld:pubmed
pubmed-article:17364219pubmed:authorpubmed-author:TogashiKaoriKlld:pubmed
pubmed-article:17364219pubmed:authorpubmed-author:KimuraTakeshi...lld:pubmed
pubmed-article:17364219pubmed:authorpubmed-author:KomedaMasashi...lld:pubmed
pubmed-article:17364219pubmed:authorpubmed-author:TadamuraEijiElld:pubmed
pubmed-article:17364219pubmed:authorpubmed-author:WuYen-WenYWlld:pubmed
pubmed-article:17364219pubmed:authorpubmed-author:YamamuroMasak...lld:pubmed
pubmed-article:17364219pubmed:authorpubmed-author:MaruiAkiraAlld:pubmed
pubmed-article:17364219pubmed:authorpubmed-author:TomaMasanaoMlld:pubmed
pubmed-article:17364219pubmed:authorpubmed-author:KanaoShotaroSlld:pubmed
pubmed-article:17364219pubmed:issnTypePrintlld:pubmed
pubmed-article:17364219pubmed:volume23lld:pubmed
pubmed-article:17364219pubmed:ownerNLMlld:pubmed
pubmed-article:17364219pubmed:authorsCompleteYlld:pubmed
pubmed-article:17364219pubmed:pagination757-65lld:pubmed
pubmed-article:17364219pubmed:meshHeadingpubmed-meshheading:17364219...lld:pubmed
pubmed-article:17364219pubmed:meshHeadingpubmed-meshheading:17364219...lld:pubmed
pubmed-article:17364219pubmed:meshHeadingpubmed-meshheading:17364219...lld:pubmed
pubmed-article:17364219pubmed:meshHeadingpubmed-meshheading:17364219...lld:pubmed
pubmed-article:17364219pubmed:meshHeadingpubmed-meshheading:17364219...lld:pubmed
pubmed-article:17364219pubmed:meshHeadingpubmed-meshheading:17364219...lld:pubmed
pubmed-article:17364219pubmed:meshHeadingpubmed-meshheading:17364219...lld:pubmed
pubmed-article:17364219pubmed:meshHeadingpubmed-meshheading:17364219...lld:pubmed
pubmed-article:17364219pubmed:meshHeadingpubmed-meshheading:17364219...lld:pubmed
pubmed-article:17364219pubmed:meshHeadingpubmed-meshheading:17364219...lld:pubmed
pubmed-article:17364219pubmed:meshHeadingpubmed-meshheading:17364219...lld:pubmed
pubmed-article:17364219pubmed:meshHeadingpubmed-meshheading:17364219...lld:pubmed
pubmed-article:17364219pubmed:meshHeadingpubmed-meshheading:17364219...lld:pubmed
pubmed-article:17364219pubmed:meshHeadingpubmed-meshheading:17364219...lld:pubmed
pubmed-article:17364219pubmed:meshHeadingpubmed-meshheading:17364219...lld:pubmed
pubmed-article:17364219pubmed:meshHeadingpubmed-meshheading:17364219...lld:pubmed
pubmed-article:17364219pubmed:meshHeadingpubmed-meshheading:17364219...lld:pubmed
pubmed-article:17364219pubmed:meshHeadingpubmed-meshheading:17364219...lld:pubmed
pubmed-article:17364219pubmed:year2007lld:pubmed
pubmed-article:17364219pubmed:articleTitleMyocardial viability by contrast-enhanced cardiovascular magnetic resonance in patients with coronary artery disease: comparison with gated single-photon emission tomography and FDG position emission tomography.lld:pubmed
pubmed-article:17364219pubmed:affiliationDepartment of Diagnostic Imaging, Kyoto University Graduate School of Medicine, 54 Shogoinkawahara, Sakyo-ku, Kyoto, 606-8507, Japan.lld:pubmed
pubmed-article:17364219pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17364219pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17364219lld:pubmed